Oxford Asset Management’s Cantel Medical Corporation CMD Stock Holding History

Oxford Asset Management’s Portfolio CMD Stock Details CMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-9,609	Closed	-$939K	–	2038
2018 Q2	$939K	Sell	9,609 -3,557	-27%	-$398K	0.02%	1071
2018 Q1	$1.47M	Buy	+13,166	New	+$1.48M	0.03%	744
2017 Q2	–	Sell	-2,636	Closed	-$211K	–	1773
2017 Q1	$211K	Buy	+2,636	New	+$209K	0.01%	1303

Other funds holding CMD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

FAM

Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

Diker Management New York $112M AUM 59.78% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

CCA

Conestoga Capital Advisors Wayne, Pennsylvania $5.01B AUM 6.26% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Oxford Asset Management's CMD Position: Q3 2018 in Review

Oxford Asset Management sold out of Cantel Medical Corporation (CMD) in Q3 2018, closing a stake of 9,609 shares — an estimated $939K sold.

Oxford Asset Management first reported a position in CMD in Q1 2017 and held it in 3 quarters. The position peaked at $1.47M in Q1 2018. 286 funds tracked by Wall St. Rank hold CMD as of Q3 2018.

Oxford Asset Management reported no remaining Cantel Medical Corporation position as of Q3 2018 after selling out during the quarter.
Oxford Asset Management sold 9,609 Cantel Medical Corporation shares in Q3 2018, an estimated $939K.
Oxford Asset Management first reported a position in Cantel Medical Corporation in Q1 2017 and held it in 3 quarters.
Oxford Asset Management's Cantel Medical Corporation position peaked at $1.47M in Q1 2018.
286 funds tracked by Wall St. Rank held Cantel Medical Corporation as of Q3 2018.

Based on Oxford Asset Management's 13F filing for Q3 2018, filed 14 Nov 2018.